Biocom’s Tim Ingersoll is out with the latest Deals and Data. Among other things, he provides news from Arena Pharmaceuticals, which underwhelmed Wall Street this week with data on its obesity drug.

Ingersoll’s column also touches on the world of nanotechnology and a blunder by the Reuters news service involving Apple founder Steve Jobs.

DAVID WASHBURN

Leave a comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.